# Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission

> **NCT00002458** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** monoclonal antibody 3F8

## Key facts

- **NCT ID:** NCT00002458
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1987-11
- **Primary completion:** 2001-09
- **Final completion:** 2001-09
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002458, "Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*